GSK revenue and financials

GSK · NYSE · USD

Secondary listing. The primary listing is GSK · LSE (GBp)

$46.60Change from previous close: +0.11%Absolute change: +$0.05

Close · October 6, 2026

In the fiscal year ended December 2025, GSK reported revenue of £32.67B (+4.11% year over year). Net income was £5.72B, a net margin of 17.5%.

Annual revenue · 2025: £32.67B
  1. £27.89B2016
  2. £30.19B2017
  3. £30.82B2018
  4. £33.75B2019
  5. £24.35B2020
  6. £24.7B2021
  7. £29.32B2022
  8. £30.33B2023
  9. £31.38B2024
  10. £32.67B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+4.11%
2025 vs 2024
Net income growth
+121.98%
2025 vs 2024
Net margin
17.5%
2024: 8.2%

Financial data

Amounts in millions of GBP; per-share values in GBP; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue32,66731,37630,32829,32424,69624,35433,75430,82130,18627,889
Cost of revenue9,0179,0488,5659,5548,1637,92911,86310,24110,3429,290
Gross profit23,65022,32821,76319,77016,53316,42521,89120,58019,84418,599
Selling, general and administrative9,01310,8479,1568,1796,784—————
Research and development7,5256,4016,2235,4885,0194,7934,5683,8934,4763,628
Operating income7,9324,0216,7456,4334,3575,9796,9615,4834,0872,598
EBIT9,4476,1908,4037,3225,634—————
EBITDA11,3358,31910,5079,2937,756—————
Interest expense701669792879769874912798734736
Pre-tax income7,4013,4776,0645,6283,599—————
Income tax1,11252675670783.067.09537541,356877
Net income5,7162,5754,92814,9564,3855,7494,6453,6231,532912
Net income to common shareholders5,7162,5754,92814,9564,385—————
Basic EPS1.410.631.223.711.101.440.940.740.310.19
Diluted EPS1.390.621.203.661.081.430.930.730.310.19
Average shares (basic)4,0514,0774,0524,0264,003—————
Average shares (diluted)4,1174,1424,1114,0844,052—————
Dividend per share0.660.610.580.611.00—————